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Abstract
The aim of this study is to examine the reproductive history of human immunodeﬁciency virus (HIV)-positive women, before and after
HIV diagnosis, to describe the characteristics of women with pregnancies after HIV diagnosis, and to assess the prevalence of
mother-to-child transmission.
A cross-sectional study was performed among women within reproductive ages (18–49) selected from the cohort in the Spanish
AIDS Research Network (CoRIS). A descriptive analysis of the pregnancy outcomes was made according to women’s serostatus at
themoment of pregnancy and association of women’s characteristics with having pregnancy after HIV diagnosis was evaluated using
logistic regression models.
Overall, 161 women were interviewed; of them, 86% had been pregnant at least once and 39% after HIV diagnosis. There were
347 pregnancies, 29% of them occurred after HIV diagnosis and in these, 20% were miscarriages and 29% were voluntary
termination of pregnancy. There were 3 cases of mother-to-child transmission among the 56 children born from HIV-positive
mothers; in these cases, women were diagnosed during delivery. Having a pregnancy after HIV diagnosis was more likely when the
younger women were at the time of diagnosis: odds ratio (OR)=1.29 (95% conﬁdence interval 0.40–4.17) for 25 to 29 years old,
OR=0.59 (0.15–2.29) for 30 to 34 years old, OR=0.14 (0.03–0.74) for ≥35 years old, compared with those<25 years at diagnosis,
who were diagnosed for ≥5 years (OR=5.27 [1.71–16.18]), who received antiretroviral treatment at some point (OR=9.38
[1.09–80.45]), and who received information on reproductive health (OR=4.32 [1.52–12.26]).
An important number of pregnancies occurred after HIV diagnosis, reﬂecting a desire for motherhood in these women.
Reproductive and sexual health should be tackled in medical follow-ups.
Abbreviations: CI= conﬁdence interval, HCV= hepatitis C virus, HIV= human immunodeﬁciency virus, IDU= injecting drug user,
IQR = interquartile range, MTCT = mother-to-child transmission, OR = odds ratio, VTP = voluntary termination of pregnancy.
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1. Introduction
Around 46% of the people living with human immunodeﬁciency
virus (HIV) worldwide are women.[1] In Spain, during the period
2008 to 2013 approximately 18% of the new HIV diagnoses
were in women.[2] Most of the diagnoses in women happened
between the ages of 25 to 39 years old, which within a women’s
reproductive age, making imperative to address in these patients
some gender-speciﬁc issues, such as reproductive desire,
contraceptive use, and pregnancy. The detection of an HIV
infection may have a signiﬁcant impact on women’s decision on
whether or not to have children and on whether to continue or to
terminate a pregnancy, but few studies have addressed this issue
in depth.[3–5]
In the early years of the epidemic, mother-to-child transmission
(MTCT)was amajor route of HIV acquisition as there was a high
risk of infection for the newborn, but with the introduction of
antiretroviral therapy vertical transmission diminished dramati-
cally, and in the period from 2008 to 2013 only 49 cases of
MTCT occurred in Spain.[2] Still, the fear of transmitting HIV to
the newborn continues to inﬂuence HIV-positive women when
thinking about childbearing, even when the improved life
expectancy and quality of life in HIV-positive patients make
having children a more popular option.[2,4,6–8]
The main objective of this study was to explore the
reproductive history of HIV-positive women, before and after
HIV diagnosis, to describe the characteristics of women with
pregnancies after HIV diagnosis, and to assess the prevalence of
MTCT.
2. Methods
2.1. Design, simple frame, and subjects
A cross-sectional observational study was designed within the
cohort of HIV-positive adults in the AIDS Research Network
(CoRIS). CoRIS is a prospective, open, and multicenter cohort of
patientsnewlydiagnosedwithHIVnaïve toantiretroviral treatment
at cohort entry of 28 centers participating from 13 Autonomous
Regions of Spain.[9,10] Nine hospitals and one sexually transmitted
disease clinic in each of 8 cities (Madrid, Valencia, Logroño, Santa
Cruz de Tenerife, Elche, Alicante, Murcia, and Donostia) from 6
Autonomous Communities participated in this study (see Annex 1,
http://links.lww.com/MD/B537). The study was approved by the
Ethics Committee of the Institute of Health Carlos III (approved in
2012) and each patient signed an informed consent form.
In the ﬁrst phase of the study, all women between 18 and 49
years old in the CoRIS cohort in all the participating settings were
included until January 2010. A healthcare provider in each
participating center contacted the selected women to explain the
project and to request their participation and written consent.
When the coordinating center received the signed consent, in the
second phase a person from the research team contacted each
woman by phone to conduct the interview. Among 494 women
selected in the ﬁrst phase of the study, 240 (48%) could not be
located or no longer had follow-ups in the hospital or clinic. Of
the remaining 254, 63 (25%) refused, 36 (14%) were excluded
for different reasons (not speaking Spanish, not having a
telephone, living on the street, or being in prison) and 155
(61%) agreed to participate. One of the hospitals participating
started to recruit subjects when the ﬁeldwork was almost
completed, and because of that, only 6 women from this hospital
were included. Finally, a total of 161 women were interviewed
between November 2011 and December 2012.
2.2. Deﬁnition of variables
A structured ad hoc questionnaire (see Annex 2, supplemental
content, http://links.lww.com/MD/B538) was designed and
administered through telephone interviews by 2 trained
researchers between November 2011 and April 2012. Informa-
tion on sociodemographic and clinical characteristics, and sexual
and reproductive history was collected.
We included, among other sociodemographic variables:
country of origin (categorized as “Spain” or “Other countries”
which was subsequently categorized to “Europe,” “Latin
America,” or “Africa”), educational level (“low” for no formal
education or only primary education, “medium” for complete
secondary education, and “high” for university degree), and
current occupational status (“employed,” “unemployed,” or
“other”—which included students, homemakers, and pen-
sioners).
Clinical variables comprised: HIV transmission category
(injecting drug user [IDU]/heterosexual contact/other), hepatitis
C virus (HCV) (positive/negative), AIDS deﬁning conditions (Yes/
No), time sinceHIV diagnosis (“<5,” “5–10,” and “>10” years),
and nadir CD4 count (“<200 CD4 cell/mm3” or “200 or more
CD4 cell/mm3”).
Data about current partners and cohabitation status were also
gathered and grouped into “has a stable partner and they live
together,” “has a stable partner but they do not live together,”
and “no stable partner.” Women were asked about the total
number of sexual partners in the last 12months as well as the type
of sexual partner (stable or occasional) and whether they had
unprotected sexual intercourse.
Women were asked to state if they had looked for or received
information on sexual and reproductive health and whether they
had disclosed their HIV infection to their closest relatives and
friends. Social support was evaluated through a 4-itemMOS-SSS
version, with a range going from 1 (none of the time) to 5 (all of
the time) for each item. “Social support”was classiﬁed as “Low”
when the score was below 12 points and “Medium” if the score
was 12 points or higher.
The main outcomes of this analysis were about pregnancies
and their results. So, “pregnancy outcomes”were deﬁned as “live
birth” if the pregnancy was carried to term and the newborn lived
at least 7 days, “voluntary termination of pregnancy (VTP)” if
woman decided not to continue the pregnancy and “miscarriage”
if it was a spontaneous loss of the fetus. We also collected
motivations for the VTP (“Financial issues,” “Professional/work-
related issues,” “Personal issues,” “Health issue,” “Active
consumption of drugs,” and “Do not know/Do not answer”),
the existence of a premature birth (labor occurred prior to 37
weeks of pregnancy or before), and type of labor (vaginal/
caesarean section). The newborn’s HIV diagnosis and antiretro-
viral treatment were also reported.
Data were analyzed according to the moment of the pregnancy
in relation to HIV diagnosis: “Before HIV diagnosis” if the
pregnancy had occurred before HIV diagnosis and “After HIV
diagnosis” if the pregnancy had occurred after HIV diagnosis or
HIV diagnosis occurred during pregnancy or delivery.
Finally, we compared the characteristics of women who had
been pregnant after HIV diagnosis with those women who had
been pregnant only before their HIV diagnosis, who had never
been pregnant or who had discovered their HIV diagnosis during
pregnancy or delivery. In the group of women who had been
pregnant after HIV diagnosis were included those women who
had had pregnancies before and after their HIV diagnosis.
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This analysis was rerun excluding those women who had never
been pregnant as sensitivity analysis (data not shown).
2.3. Statistical analysis
Pregnancies’ characteristics were described according to women’s
serostatus using frequency tables for categorical variables and
median and interquartile range (IQR) for continuous ones. The P
values were estimated using robust methods that assumed
correlations between pregnancies which occurred in the same
woman and independence among women recruited.
Multivariable logistic regression models were ﬁtted to evaluate
association of women’s characteristics with having pregnancy
after HIV diagnosis. Crude and adjusted odds ratios (ORs) with
their 95% conﬁdence intervals (95% CIs) were obtained as the
measure of association.
All statistical analyses were performed using Stata software
(Version 13.0, College Station, TX).
3. Results
3.1. Characteristics of the participants
Table 1 shows the characteristics of women at the time of the
interview.
The median age of the 161 women at the time of the interview
was 38 years (IQR 32–44). Spanish origin accounted for 56.5%
(n=91) while the remaining 43.5%was divided into: 48.6% (n=
34) from Latin America, 27.1% (n=19) from Europe (10 from
Russia), 24.3% (n=17) from Africa, and 7 from Equatorial
Guinea. The median time of residence in Spain of these non-
Spanish women was 8 years (IQR 4–11).
Most of the women interviewed (75.2%) had secondary
education and nearly half (49.1%) worked outside their home at
the time of the interview. Women with a partner accounted for
64.6% (n=104), all male, and 81 (77.8%) cohabited at the time
of the interview. Of those partners, 41.3% (n=43) were also
diagnosed with HIV and only 1 partner had an unknown HIV
serostatus.
Women had been diagnosed in median 4 years (IQR 2–7)
before the interview. Unprotected sex was the main route of HIV
acquisition (82.6%, n=133) while 13.0% (n=21) were injecting
drug users. Around 13.0% (n=21) had suffered anAIDS deﬁning
illness and 81.4% (n=131) had received antiretroviral treatment
at some point. HCV infection was found in 17.4% (n=28).
3.2. Reproductive history
Of the 161 interviewed women, 14.3% (n=23) had never been
pregnant, 52.2% (n=84) had gone through 1 or 2 pregnancies,
22.4% (n=36) had 3 or 4 pregnancies, and 11.2% (n=18) had 5
or more pregnancies (data not shown). Regarding HIV
serostatus, of the 138 women who became pregnant, only 75
become pregnant before HIV diagnosis, only 24 after HIV
diagnosis, and 39 before and after HIV diagnosis. The percentage
of nulliparous women was 31.0% (n=50), 57.1% (n=92) had 1
or 2 children, and 11.8% (n=19) had 3 or more children. This
gave a total of 347 pregnancies and 201 children born.
Table 2 shows the characteristics of the 347 pregnancies
according to women’s HIV serostatus.
Of the 347 pregnancies (138women), 246 (70.9%) (65women)
occurred before the women were diagnosed with HIV and the
remaining 101 (29.1%) afterward. These 101 pregnancies
occurred among 63 women. At the time of the interview 5 women
were pregnant. The median time between HIV diagnosis and the
ﬁrst pregnancy after HIV diagnosis was 2 years (IQR 1–4 years),
excluding pregnancies with a diagnosis during antenatal care.
No statistically signiﬁcant differences were observed in the
percentage of pregnancies to full term before and after HIV
Table 1
Sociodemographic, sexual behavior, and clinical characteristics of
161 women interviewed.
N %
Sociodemographic variables
Age at interview, y
<30 28 17.4
30–39 61 37.9
≥40 72 44.7
Country of origin
Spain 91 56.5
Others 70 43.5
Educational level
Without or primary school 19 11.8
Secondary school 121 75.2
University 21 13.0
Current occupational status
Employed 79 49.1
Unemployed 54 33.5
Others
∗
28 17.4
Clinical variables
Age at diagnosis, y
<25 31 19.2
25–29 36 22.4
30–34 30 18.6
≥35 64 39.7
Route of HIV transmission
Injecting drug users 21 13.0
Heterosexuals 133 82.6
Others 7 4.4
Have ever received antiretroviral treatment
Yes 131 81.4
No 30 18.6
Have ever diagnosed of any AIDS deﬁning conditions
Yes 21 13.0
No 140 87.0
Nadir CD4 count‡
<200 57 37.2
≥200 96 62.8
Sexual behavior variables
Current partner and cohabitation status
With a partner and living together 81 50.3
With a partner but not living together 23 14.3
Without a partner 57 35.4
Number of total partners
<4 50 31.1
<4–10 69 42.9
>10 25 15.5
Do not remember 17 10.6
Information about reproduction
No 89 55.3
Yes 72 44.7
Disclosure HIV status to their familiar circle 139 87.9
Yes
No 19 12.0
Social support
Low 22 14.0
Normal 135 86.0
AIDS = acquired immune deﬁciency syndrome, HIV = human immunodeﬁciency virus.
∗
Other occupational situation: student, homemaker, and pensioner.
‡ Eight women had no data about nadir CD4 count.
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diagnosis in women (58.9% vs 58.4%, respectively; P=0.937),
or regarding the number of preterm births (17.9% vs 16.1%, P=
0.755), but a signiﬁcant increase in the percentage of cesarean
deliveries, 20.0% to 51.8% (P < 0.001) was found.
In pre-HIV diagnosis pregnancies, 9.7% (n=24) of them,
women knew their male partners to be HIV-positive, while
25.5% (n=63) did not know the serostatus of their partners. In
post-HIV pregnancies, 36.0% (n=36) occurred with a serocon-
cordant partner, 47.0% (n=47) with a discordant one and in
17.0% (n=17) the serostatus of the partner was unknown.
3.3. Miscarriages
Of the 138 women who had been pregnant at least once in their
life, 18.1% (n=25) had 1 or 2 miscarriages and 5.1% (n=7) 3 or
more. Out of the 347 recorded pregnancies, 14.0% (n=48)
ended in spontaneous miscarriage increasing to 19.8% (n=19)
when taking into consideration only pregnancies after diagnosis
(P=0.092).
3.4. Voluntary termination of pregnancy
Ofthe138womenwithpregnancies,36.2%(n=50)hadundergone
1or2VTPsand5.7%(n=8)3ormore, leading to27.2%(n=93)of
all pregnancies ending in VTP. In pregnancies occurring before the
diagnosis of HIV, 29.3% (n=72) were VTP in contrast to 21.8%
(n=21) in pregnancies after diagnosis (P=0.239).
The reasons given bywomen to undergo VTP varied depending
on whether the pregnancy occurred before or after the diagnosis
of HIV (P<0.001). The main reason for women to end a
pregnancy before HIV diagnosis was “Personal issues” (68.1%,
n=49), a category that included being too young, lacking a stable
partner, interference with studies/career, or not wanting children
at that moment. The next most selected reason, with 15.3% (n=
11), was the “Active consumption of drugs” at the time of the
pregnancy, and other motives stated were “Financial issues”
5.6% (n=4), “Health issues” 2.8% (n=2), “Professional/work-
related issues” 1.4% (n=1). Finally, 6.9% (n=5) did not disclose
a reason or were unwilling to answer this question.
Regarding the reasons claimed by women after HIV diagnosis,
“Personal issues” remained the most important with a 42.9%
(n=9) although the reasons under this category were slightly
different from the previous group: not wanting children and
short-term partner or problematic relationship. “Health issues”
increased to 38.1% (n=8), mainly due to HIV infection while
14.3% (n=3) claimed “Financial issues” and 4.8% (n=1)
“Professional/work-related issues.”
3.5. Use of assisted reproduction techniques
Only 4 of the 347 pregnancies occurred through assisted
reproduction techniques and 3 took place after the HIV diagnosis
of the women. The techniques undergone were artiﬁcial
fertilization with intracytoplasmic injection for the pregnancy
before HIV diagnosis (2001), and 2 artiﬁcial inseminations (2008
and 2009) and 1 in vitro fertilization with donated oocytes for the
pregnancies after HIV diagnosis (2011). In 1 of these 4 cases
sperm washing was performed due to HIV/HCV co-infection.
3.6. Antiretroviral therapy during pregnancy and HIV
vertical transmission to the newborn
Of 101 pregnancies after HIV diagnosis, 61.4% (n=62) were
pregnancies in women receiving antiretroviral treatment. Of the
Table 2
Characteristics of 347 pregnancies according to HIV serostatus of women.
Time of pregnancy
Total, n (%) Before HIV diagnosis, n (%)‘ After HIV diagnosis, n (%) P
Pregnancies 347 (100) 246 (70.9) 101 (29.1)
Outcomes n=342 n=246 n=96
∗
Live birth 201 (58.8) 145 (58.9) 56 (58.4) 0.388
Miscarriage 48 (14.0) 29 (11.8) 19 (19.8)
VTP 93 (27.2) 72 (29.3) 21 (21.8)
Reasons for VTP n=93 n=72 n=21
Financial 7 (7.5) 4 (5.6) 3 (14.3) 0.0067
Professional 2 (2.2) 1 (1.4) 1 (4.8)
Personal 58 (62.4) 49 (68.1) 9 (42.9)
Health 10 (10.8) 2 (2.8) 8 (38.1)
Drug use 11 (11.8) 11 (15.3) 0
Do not know/do not answer 5 (5.4) 5 (6.9) 0
Preterm delivery n=201 n=145 n=56
Yes 35 (17.4) 26 (17.9) 9 (16.1) 0.768
No 166 (82.6) 119 (82.1) 47 (83.9)
Type of delivery n=201 n=145 n=56
Vaginal 143 (71.1) 116 (80.0) 27 (48.2) 0.0002
Caesarean 58 (28.9) 29 (20.0) 29 (51.8)
Serostatus HIV of the partner n=347 n=246 n=101
Positive 60 (17.3) 24 (9.8) 36 (35.6) 0.011
Negative 207 (59.6) 159 (64.6) 48 (47.5)
Unknown 80 (23.1) 63 (25.6) 17 (16.8)
Pregnancies by assisted reproductive treatments n=347 n=246 n=101
Yes 4 (1.2) 1 (0.4) 3 (3.0) 0.0886
No 343 (98.8) 246 (99.6) 98 (97.0)
HIV = human immunodeﬁciency virus, VTP= voluntary termination of pregnancy.
∗
Except 5 pregnancies in process during interviews.
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39 pregnancies in which women did not receive antiretroviral
treatment, 31 (79.5%) ended in miscarriages or voluntary
terminations, and in 4 women (10.2%) HIV diagnoses were
during the last trimester of pregnancy or childbirth and in the
remaining cases there was no information about this.
Of the 56 pregnancies to term in women with HIV infection, 3
children were infected with HIV, which gives a prevalence of
5.4%. These 3 cases of vertical transmission occurred in 1988,
1993, and 2004. In the cases of the children born in 1988 and
2004, the HIV diagnosis in the mother was made during labor.
And in the case of the child born in 1993, the mother was
diagnosed during the last pregnancy trimester follow-up. Neither
of the mothers had received antiretroviral treatment. Otherwise,
there was no vertical transmission among those mothers who
received antiretroviral therapy even though when they were
diagnosed during the prenatal follow-up.
The child born in 1988 did not receive antiretroviral treatment
while the child born in 1993 did; in the case of the child born in
2004, the mother did not recall if the baby had received treatment
or not. The remainder of the children received antiretroviral
prophylaxis at birth.
In the 145 pregnancies to term inwomen beforeHIV diagnosis,
2 children were diagnosed with HIV infection retrospectively
after their mother’s diagnosis, at the age of 6 and 2 years.
Pregnancy and childbirth of these 2 women occurred at their
home countries, Ecuador, and Paraguay, while the diagnosis of
HIV infection occurred when residing in Spain and attending
health services due to health issues.
3.7. Factors associated with having pregnancies after HIV
diagnosis
Table 3 shows the results of the bivariate and multivariable
analyses of factors associated with having had a pregnancy after
HIV diagnosis versus not having a pregnancy or having it before
HIV diagnosis.
Of the 161 women interviewed, 28 (17.4%) had a pregnancy
after HIV diagnosis, compared with 133 (82.6%) who either had
no pregnancy or only had pregnancies before diagnosis
(including HIV diagnosis during pregnancy or delivery).
In the multivariate analysis, being pregnant after diagnosis was
associated with being younger at the time of diagnosis, OR=1.29
(95%CI0.40–4.17) for those ages 25 to 29 years,OR=0.59 (95%
CI0.15to2.29) for thosebetween30and34years,OR=0.14(95%
CI0.03–0.74) for thosewhowere older than35years, compared to
thosewith<25yearsatdiagnosis. Itwasalsoassociatedwithhaving
been diagnosed for 5 or more years, (OR=5.27, 95% CI
1.71–16.18), having received antiretroviral therapy at some point
(OR=9.38, 95%CI1.09–80.45), andhaving received information
on reproductive health (OR=4.32, 95% CI 1.52–12.26).
4. Discussion
Most of thewomen interviewed, 85.7%had been pregnant at least
once in their life and 17.4% had a pregnancy after HIV diagnosis,
accounting for 29.1% of all pregnancies. This percentage of
womenwho had become pregnant after receiving their diagnosis is
lower than that found in studies in Europe andUnited Stateswhere
the percentage is between 25% and 35%.[5,11,12]
In our study, 21.7% of the women were diagnosed with HIV
during pregnancy follow-up visits. In 3 of them, HIV diagnosis
was made during labor. This highlights the importance of
detecting cases through antenatal screening inwomenwho do not
feel at risk of acquiring the infection. Spain has adopted an opt-
out strategy for HIV screening in pregnant women and
recommends repetition of the test in the last trimester. If the
woman is unaware of her HIV status at the time of childbirth, a
rapid test is done to detect HIV antibodies and put in place
preventive measures in case of a positive result.[13] On the other
hand, the cases detected during labor indicate the existence of
important gaps in the health system that allowwomen to arrive to
childbirth without any antenatal monitoring. Compared with
women diagnosed during pregnancy follow-up, diagnosis at birth
is clearly a missed opportunity for early diagnosis of HIV
infection, which affects the mother and the newborn, and
increases the risk of vertical transmission. In our study, the 3
children who were diagnosed with HIV were from mothers
diagnosed during childbirth.
As for the pregnancies to term, no differences between
pregnancies occurring before and after diagnoses were observed.
Similarly, Massad et al[14] observed that HIV-positive women
had fewer pregnancies than HIV-negative ones, but found no
differences in pregnancy outcome with respect to prematurity or
birth weight.
We observed a rise in caesarean section deliveries in HIV-
positive women. Caesarean section delivery has been one of the
main guideline recommendations to prevent vertical transmission
togetherwith giving antiretroviral therapy to pregnantwomenand
newborns, and avoiding breastfeeding. However, in recent years,
several studies have shown that opting for a vaginal delivery when
the woman is under antiretroviral therapy and the viral load is
suppressed is an adequate alternative. The vertical transmission
rate observed among women taking antiretroviral treatment is
similar if the delivery is vaginal or through cesarean section[15–17]
and a study by the European Collaborative Study observed an
increased risk ofMTCT inwomenwho had an inadequate control
of their antenatal antiretroviral therapy.[18] Therefore at this point
we consider adherence to antiretroviral treatment in pregnant
women with HIV infection to be paramount.
The diagnosis of HIV infection is a turning point in the sexual
lives of thesewomen, causing changes in their relationships and the
use of contraceptive methods. Among the women who tested
positive for HIV, 10.6% stopped having sex and the percentage of
women who did not use contraception during sex decreased while
the use of condom signiﬁcantly increased.[19] However, a
substantial number of VTPs was observed after HIV diagnosis,
possibly indicating thatmanyof thesepregnancieswereunplanned.
The percentage of VTPs after HIV diagnosis was 21.8%, similar to
what we have seen in other recent studies in Europe[5,7] and the
United States.[13]Although it is still an important percentage it is far
belowwhat was appreciated in the ﬁrst decade of the epidemic and
before the existence of combination antiretroviral therapy, when
the incidence of pregnancy was signiﬁcantly lower and VTP was
very high after HIV diagnosis.[3,20]
It is worth noting the reasons given for VTP by women before
and after HIV diagnosis. Before being diagnosed with HIV
“Personal issues” was very frequent, especially being too young,
interference with studies/career, the lack of stability in the
relationship and the active use of drugs. After diagnosis, although
HIV infection by itself was an important cause for VTP,
“Personal issues” remained the main reason. In a study in
Brazilian women with HIV infection, in addition to the fear of
HIV transmission, the number of previous children, ﬁnancial
issues and the inﬂuence of family or medical opinion inﬂuenced
the decision to terminate the pregnancy.[21] Overall, these results
show that information on use of contraception and reproductive
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health is lacking both in seropositive and seronegative women,
suggesting that family planning services should improve. An
unplanned pregnancy increases the risk of HIV transmission to
the newborn and the probability of VTP.[20,22]
The factors associated with having a pregnancy after diagnosis
were being diagnosed at a younger age, having received
antiretroviral therapy at some point, and having received or
sought information on sexual and reproductive health. Age at
Table 3
ORs for the association between becoming pregnant after HIV diagnosis and sociodemographic, clinical, and sexual behavior variables.
Bivariate analyses Multivariable analyses
N % OR 95% CI OR 95% CI
Number of women had pregnant after HIV diagnosis 28/161 17.4
Age at interview, y
<30 6/28 21.4 1
30–39 12/61 19.7 0.89 0.29–2.70
≥40 10/72 13.9 0.59 0.19–1.82
Country of origin
Spain 16/91 17.6 1
Others 12/70 17.1 0.97 0.42–2.20
Educational level
Without or primary school 3/19 15.8 1
Secondary school 21/121 17.4 1.12 0.30–4.19
University 4/21 19.0 1.25 0.24–6.50
Current occupational status
Employment 10/79 12.6 1
Unemployment 13/54 24.1 2.19 0.88–5.43
Others 5/28 17.8 1.50 0.46–4.84
Age at diagnosis, y
<25 10/31 32.2 1 1
25–29 11/36 30.6 0.92 0.33–2.60 1.29 0.40–4.17
30–34 5/30 16.7 0.42 0.12–1.42 0.59 0.15–2.29
≥35 2/64 3.1 0.07 0.01–0.33 0.14 0.03–0.74
Time since HIV diagnosis, y
<5 5/77 6.5 1 1
≥5 23/79 29.1 6.32 2.26–17.65 5.27 1.71–16.18
Route of HIV transmission
Injecting drug users 7/21 33.3 1
Heterosexual 19/133 14.3 0.33 0.12–0.93
Others 2/7 28.6 0.80 0.12–5.21
Have ever-received cART
No 1/30 3.3 1 1
Yes 27/131 20.6 7.52 0.98–57.8 9.38 1.09–80.45
Have ever diagnosed of AIDS events
No 26/140 18.6 1
Yes 2/21 9.5 2.17 0.47–9.88
Nadir CD4 count, cell/mm3
<200 8/57 14.0 1
≥200 18/96 18.8 1.41 0.57–3.49
Pregnancy before HIV diagnosis
Yes 17/114 14.9 1
No 11/47 23.4 1.74 0.74–4.07
Number of total children
None 7/50 14.0 1
1 or 2 19/92 20.6 1.60 0.62–4.11
3 or more 2/19 10.5 0.72 0.14–3.83
Current partner and cohabitation status
With a partner and living together 18/81 22.2 1
With a partner but not living together 5/23 21.7 0.97 0.32–2.98
Without a partner 5/57 8.8 0.34 0.11–0.97
Information about reproduction
No 7/89 7.9 1 1
Yes 21/72 29.2 4.82 1.91–12.15 4.32 1.52–12.26
Disclosure HIV status to their familiar circle
Yes 25/139 18.0 1
No 3/19 15.8 0.85 0.23–3.15
Social support
Low 3/22 13.6 1
Normal 25/135 18.5 0.69 0.19–2.53
AIDS = acquired immune deﬁciency syndrome, cART = combined antiretroviral therapy, CI = conﬁdence interval, HIV = human immunodeﬁciency virus, OR = odds ratio.
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diagnosis was the most important factor implied in the desire for
procreation and pregnancy in these women.[5,11,23] The existence
of combined antiretroviral therapy was also an incentive for
women to go through motherhood. Improvements in antiretro-
viral treatment efﬁcacy increased the number of pregnancies
amongHIV-positive women and the decline in abortions could be
related to women’s knowledge of a lower risk of transmission to
the baby, along with a better perception of their health.[24]
Consulting a doctor or seeking information on reproductive
health was also associated with having pregnancies after
diagnosis. The involvement of health workers in giving
reproductive, contraception, and sexual advice is essential for
these women to normalize their sexual and emotional life. Many
women would appreciate receiving advice from their physician
on reproductive health, however, this rarely occurs,[25,26] even
when proof exists of it declining unwanted pregnancies and
therefore the number of abortions.[22]
This study has a number of limitations. First, the sample size
was small, mainly due to an important number of women who
could not be located or who were not being followed up when the
study was conducted. This was especially relevant in the largest
hospitals (Madrid and Valencia), which are reference centers for
HIV. It is easier for a patient to seek care in the initial phase after
diagnosis and then be referred to another center closer to their
home. However, no signiﬁcant differences were observed
between the women who were and were not interviewed (data
not shown). Second, information about pregnancies was
collected retrospectively and self-reported, so our results might
be affected by recall bias, especially among ﬁrst pregnancies and
those before HIV diagnosis. The ad hoc questionnaire was
carefully designed by the working group with a special focus in
reducing the impact of this bias. Besides, the interviewers were
trained to create a trustful atmosphere during the interviews.
Although our sample size was low, this studywas nested within
a cohort of patients recruited with high representation of the
situation of the HIV epidemic in Spain which makes us believe
this study provides a description of reproductive history and
aspirations of women living with HIV in Spain.
In conclusion, the number of pregnancies after HIV diagnosis
is considerable and reﬂects a clear desire for motherhood inHIV-
positive women. Nevertheless the number of VTP is still high,
indicating the need to reinforce the prevention of unplanned
pregnancies and ameliorate the correct and timely delivery of
information on sexual and reproductive health in HIV-positive
women.
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